Ensayos Clínicos

An Open-label, Randomized, Parallel-Group, Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Crohn's Disease Active Ulcerative Colitis

Ficha Técnica

Investigador Principal

JOSE MANUEL BENITEZ CANTERO

Promotor

PHARMACEUTICAL PRODUCT DEVELOPMENT SPAIN S.L.

ESTADO

CERRADO

DEPARTAMENTO

Aparato Digestivo

Código EudraCT: 2016-002124-89

Número protocolo: CT-P13 1.6

Fecha Inicio: 2017-06-29

Fecha Fin: 2019-09-30